E. Worth

451 total citations
9 papers, 347 citations indexed

About

E. Worth is a scholar working on Oncology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, E. Worth has authored 9 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Infectious Diseases and 2 papers in Molecular Biology. Recurrent topics in E. Worth's work include Bone health and treatments (2 papers), HIV Research and Treatment (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). E. Worth is often cited by papers focused on Bone health and treatments (2 papers), HIV Research and Treatment (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). E. Worth collaborates with scholars based in United Kingdom, Switzerland and United States. E. Worth's co-authors include Joanne Barrett, Frieder Bauss, Solomon Epstein, Hugh Wiltshire, Michael Brewster, Steven R. Harris, Taryn F. Moy, Julius Wenger, Paul Weigl and Dennis G. Hall and has published in prestigious journals such as Analytical Biochemistry, British Journal of Clinical Pharmacology and Drug Metabolism and Disposition.

In The Last Decade

E. Worth

9 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Worth United Kingdom	8	202	89	80	58	50	9	347
Mark Allison United States	9	137 0.7×	104 1.2×	171 2.1×	115 2.0×	30 0.6×	14	514
Jacqueline Marti-Jaun Switzerland	10	92 0.5×	4 0.0×	128 1.6×	17 0.3×	41 0.8×	15	463
Nilay Thakkar United States	9	198 1.0×	2 0.0×	117 1.5×	59 1.0×	68 1.4×	17	467
Peng Men China	12	53 0.3×	14 0.2×	70 0.9×	72 1.2×	17 0.3×	29	371
Rajendra Singh United States	11	89 0.4×	5 0.1×	116 1.4×	83 1.4×	23 0.5×	33	383
Wen-Sheng Guo United States	5	401 2.0×	8 0.1×	54 0.7×	59 1.0×	324 6.5×	5	628
Malcolm S. Ogg United Kingdom	6	66 0.3×	4 0.0×	49 0.6×	9 0.2×	19 0.4×	7	329
Randall Stoltz United States	9	27 0.1×	14 0.2×	26 0.3×	49 0.8×	15 0.3×	11	430
Patrick Purcell Australia	9	210 1.0×	136 1.5×	21 0.3×	5 0.1×	36 0.7×	12	438
Anita Shah United States	14	52 0.3×	2 0.0×	79 1.0×	28 0.5×	40 0.8×	36	605

Countries citing papers authored by E. Worth

Since Specialization

Citations

This map shows the geographic impact of E. Worth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Worth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Worth more than expected).

Fields of papers citing papers by E. Worth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Worth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Worth. The network helps show where E. Worth may publish in the future.

Co-authorship network of co-authors of E. Worth

This figure shows the co-authorship network connecting the top 25 collaborators of E. Worth. A scholar is included among the top collaborators of E. Worth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Worth. E. Worth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Reigner, Bruno, François Vandenhende, Ulrich Beyer, et al.. (2014). Bayesian adaptive designs in single ascending dose trials in healthy volunteers. British Journal of Clinical Pharmacology. 78(2). 393–400. 9 indexed citations

Pillai, Gopal S, et al.. (2006). Population pharmacokinetics of ibandronate in Caucasian and Japanese healthy males and postmenopausal females. International Journal of Clinical Pharmacology and Therapeutics. 44(12). 655–667. 14 indexed citations

Barrett, Joanne, E. Worth, Frieder Bauss, & Solomon Epstein. (2004). Ibandronate: A Clinical Pharmacological and Pharmacokinetic Update. The Journal of Clinical Pharmacology. 44(9). 951–965. 123 indexed citations

Wiltshire, Hugh, et al.. (2000). Chromatographic and Immunochemical Approaches to the Analysis of the HIV Protease Inhibitor Saquinavir in Plasma. Analytical Biochemistry. 281(1). 105–114. 15 indexed citations

Wiltshire, Hugh, Taryn F. Moy, Steven R. Harris, et al.. (2000). The Disposition of Saquinavir in Normal and P-glycoprotein Deficient Mice, Rats, and in Cultured Cells. Drug Metabolism and Disposition. 28(9). 1058–1062. 82 indexed citations

Wiltshire, Hugh, et al.. (1997). Metabolism of the calcium antagonist, mibefradil (POSICORTM, Ro 40-5967). Part III. Comparative pharmacokinetics of mibefradil and its major metabolites in rat, marmoset, cynomolgus monkey and man. Xenobiotica. 27(6). 557–571. 21 indexed citations

Wiltshire, Hugh, et al.. (1992). Metabolism of calcium antagonist Ro 40-5967: a case history of the use of diode-array u.v. spectroscopy and thermospray-mass spectrometry in the elucidation of a complex metabolic pathway. Xenobiotica. 22(7). 837–857. 16 indexed citations

Williams, P.E., et al.. (1990). Pharmacokinetics and tolerance of romazarit after oral administration of ascending single doses to healthy human volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 15(4). 317–322. 3 indexed citations

Natoff, Ian L., John Nixon, Robert J. Francis, et al.. (1985). Biological Properties of the Angiotensin-Converting Enzyme Inhibitor Cilazapril. Journal of Cardiovascular Pharmacology. 7(3). 569–580. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact